| " REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA R Latagliata, F Stagno, M Annunziata, E Abruzzese, A Iurlo, N Sgherza, ... HAEMATOLOGICA 100, 698-699, 2015 | | 2015 |
| “Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? S Bernardi, M Bonifacio, A Iurlo, C Zanaglio, M Tiribelli, G Binotto, ... European journal of haematology 103 (3), 272-273, 2019 | 28 | 2019 |
| 3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients M Malagola, A Iurlo, C Bucelli, E Abruzzese, M Bonifacio, F Stagno, ... Blood 142, 3165, 2023 | | 2023 |
| 4-Year Outcome Of 215 Patients With Newly Diagnosed Chronic Myeloid Leukemia (CML) Treated Frontline With Nilotinib In Investigator-Sponsored Studies. A Report From The Gimema … G Gugliotta, F Castagnetti, M Breccia, L Levato, G Rege-Cambrin, ... Blood, The Journal of the American Society of Hematology 122 (21), 4000-4000, 2013 | | 2013 |
| 42 Congress of the Italian Society of Hematology, Milan, Italy, October 18-21, 2009 B Casolari, G Da Rin, P Doretto, P Bulian, F Siviero aÂma [haima]= blood a· matow [haimatos]= of blood lÒgow [logos]= reasoning …, 2009 | | 2009 |
| 5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors C Filì, D Damiani, M Tiribelli HAEMATOLOGICA 95 (s2), 556, 2010 | 1 | 2010 |
| A novel denaturing high-performance liquid chromatography (D-HPLC) based method for kit mutation screening of patients (pts) with systemic mastocytosis (SM) S Colarossi, S Soverini, A Gnani, M Rondoni, S Gatto, S Merante, ... Journal of Clinical Oncology 25 (18_suppl), 7085-7085, 2007 | | 2007 |
| A novel denaturing-high performance liquid chromatography (D-HPLC) based method for kit mutation screening of patients with systemic mastocytosis S Colarossi, S Soverini, A Gnani, M Rondoni, S Gatto, S Merante, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 212-213, 2007 | | 2007 |
| A Novel Denaturing-High Performance Liquid Chromatography (D-HPLC)-Based Method for Kit Mutation Screening of Patients (pts) with Systemic Mastocytosis (SM) Allows the … S Colarossi, S Soverini, A Gnani, M Rondoni, S Gatto, S Merante, ... Blood 108 (11), 4849, 2006 | | 2006 |
| A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis F Palandri, GA Palumbo, M Bonifacio, EM Elli, M Tiribelli, G Auteri, ... Cancers 15 (20), 5027, 2023 | 2 | 2023 |
| A rapid reduction of Bcr/Abl transcripts is associated with an early cytogenetic response to Glivec (STI571) in chronic myeloid leukemia in chronic phase: a study of the … G Martinelli, F Pane, G Saglio, D Alberti, M Amabile, E Ottaviani, M Intrieri, ... BLOOD 98 (11), 615a, 2001 | | 2001 |
| A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. M Malagola, C Skert, D Damiani, A Candoni, M Tiribelli, G Martinelli, ... HAEMATOLOGICA 94 (s2), 546, 2009 | | 2009 |
| A simulation study using validated prognostic factors to assess expected long-term survival M Pfirrmann, J Hasford Methods of Information in Medicine 44 (04), 577-583, 2005 | 6 | 2005 |
| A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements M Bonifacio, L Scaffidi, MC Miggiano, D Facchinelli, L Tosoni, S Pezone, ... Blood Cancer Journal 14 (1), 53, 2024 | | 2024 |
| ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid … M Tiribelli, D Damiani, E Calistri, A Geromin, A Michelutti, M Cavallin, ... | | 2006 |
| ABCG 2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome D Damiani, M Tiribelli, A Geromin, A Michelutti, M Cavallin, A Sperotto, ... American journal of hematology 90 (9), 784-789, 2015 | 23 | 2015 |
| ABCG2 AND ABCB1 RNA LEVELS AT DIAGNOSIS AND DURING THERAPY WITH IMATINIB AND 2G-TKIS IN NEWLY DIAGNOSED CP-CML PATIENTS S Di Giusto, E Toffoletti, D Griguolo, R Stella, G Maccari, M Stulle, R Fanin, ... HAEMATOLOGICA 103, S91-S92, 2018 | | 2018 |
| ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML M Tiribelli, A Geromin, M Cavallin, S Di Giusto, E Simeone, R Fanin, ... European Journal of Haematology 99 (3), 269-274, 2017 | 15 | 2017 |
| ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients M Tiribelli, S Di Giusto, E Toffoletti, D Griguolo, D Penna, G Maccari, ... Blood 130, 1614, 2017 | | 2017 |
| ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives D Damiani, M Tiribelli International Journal of Molecular Sciences 24 (8), 7147, 2023 | 6 | 2023 |
massimo brecciaSapienza University在 bce.uniroma1.it 的电子邮件经过验证
